Slide 1: Hydrix 2019 Annual General Meeting Presentation
ASX Announcement 12/12/2019 Hydrix 2019 Annual General Meeting Presentation Hydrix Limited (Hydrix or the Company) (ASX: HYD) attaches a presentation which will be delivered by Gavin Coote (Chairman) and Peter Lewis (CEO) at Hydrix’s 2019 Annual General Meeting today. -ENDS- Authorisation: This anno
Slide 2: Chairman & CEO Update, AGM December 2019
Hydrix Limited Hydrix brings technologies to life which enhance people’s health, safety and well-being Chairman & CEO Update AGM December 2019 Page 1 Hydrix Ltd | AGM Presentation | December 2019
Slide 3: Hydrix value proposition - bring ground breaking technologies to life
Hydrix value proposition - bring ground breaking technologies to life WHAT Deliver world class product design, engineering & regulatory services to create WE DO market leading solutions which improve lives “Improve Lives” WHY WE We apply 1,000s of years of know-how to: (i) de-risk product develo
Slide 4: Strong FY19 performance – exceeded all market guidance milestones
Strong FY19 performance – exceeded all market guidance milestones Milestones - FY19 Achievements Minimum 15% revenue growth Exceeded each half year growth target by over two times Exceeded over prior half year period Full year revenue growth of 149% (FY19: $14.23m, FY18: $5.7m) 15% increase in eng
Slide 5: Hydrix has delivered strong revenue growth since acquisition
Hydrix has delivered strong revenue growth since acquisition Quarterly Revenue Growth Since Acquisition Revenue Profile Revenues are generated 1.) Innovate through fee-for-service C client project U ($m) arrangements. IP created S $4.5m is owned by client T $4.0m 2.) Design $4.2m $4.1m O Offer s
Slide 6: Global expertise in three large and growing sectors
Global expertise in three large and growing sectors We create novel solutions including connected ‘mobile’ technologies, often breaking new boundaries in reduced product size, weight & power consumption, and increased performance in highly physical use activities 1. Medical Technology 2. Consumer &
Slide 7: FY20 outlook strong, milestones on track
FY20 outlook strong, milestones on track We are a successful company Building on solid foundations Milestones for FY20 Status FY20 capital program completed in November 2019 Completed $5.0m financing arrangement with Pure Revenue growth to exceed 15% over FY19 On Track Asset Management. Paydown $3
Slide 8: Purpose of Buy, Build & Invest strategy
Purpose of Buy, Build & Invest strategy CAPTURE more value created by Hydrix’ design, engineering, regulatory and commercialisation capabilities Capital Gains Investments & acquisitions drive value: Value driven from equity investment Create recurring product revenue streams Monetize IP and earnin
Slide 9: Example of “Buy, Build, Invest” strategy initiative
Example of “Buy, Build, Invest” strategy initiative It’s about time Guardian® is the world’s first FDA approved implantable heart attack alert system using patented AI and Machine Learning algorithms o FDA approved 1st generation device in April 2018. Angel Medical seeking FDA approval for upgrade
Slide 10: Hydrix is a ‘knowledge economy business’ - with strong growth prospects
Hydrix is a ‘knowledge economy business’ - with strong growth prospects Increasing global demand for advanced engineering, regulatory & design services Strategy & Vision Recognised sector specialties: Medical Technology, Consumer & Industrial and Defense & Aerospace ‘Buy, Build & Invest’ strat
Slide 11: Disclaimer
Disclaimer This presentation has been prepared by Hydrix Limited (the “Company” or “Hydrix”). This presentation is being provided to investors for the sole purpose of providing preliminary background financial and other information to enable recipients to review the business activities of the Compan
Slide 12: Appendices
Appendices Page 11 Hydrix Ltd | AGM Presentation | December 2019
Slide 13: Hydrix – a corporate snapshot
Hydrix – a corporate snapshot Major Shareholders1 Shares (m) % Capital Structure (post transaction) John W King Nominees & Associates 166.8 21.5% Ticker HYD BNP Paribas Nominees (Acorn Capital) 34.7 4.6% Share Price2 $0.025 Flet Superannuation Pty Ltd 26.1 3.4% Shares on Issue (m) 761.2 Kurrawonga P
Slide 14: hydrix.com, 30-32 Compark Circuit, Mulgrave VIC 3170
hydrix.com 30-32 Compark Circuit Mulgrave VIC 3170 Australia ASX:HYD Page 13 Hydrix Ltd | AGM Presentation | December 2019